The global surgical apparel market, valued at around US $ 3.2 billion in 2021, is estimated to grow to about US $ 4.5 billion by 2028, growing at a CAGR of approximately 5.8 per cent.
Claiming so, a market research study of Zion Market Research, US says that this can be attributed to the increasing focus on healthcare and the rising demand for patient safety across the world. The healthcare industry is witnessing some major transformations as technological development increases and focus on public safety reinforces.
The rising geriatric population, increasing demand for patient safety, growing focus on healthcare accessibility, the prevalence of infectious chronic diseases and rising healthcare expenditure are projected to be major trends positively impacting surgical apparel market growth through 2028.
The increasing number of surgical procedures has substantially propelled the demand for surgical apparel, and coupled with the emergence of chronic and rare diseases, this has bolstered the market for surgical apparel on a global scale.
These products are mostly used in hospital for surgery – medical specialty hospitals, medicine-making companies, clinics, research centres, pharmaceutical companies, etc., like masks and clothing sectors.
China, Japan and India are anticipated to emerge as noteworthy markets in this region owing to the rapid development of healthcare infrastructure and the growing patient pool for chronic illnesses in these nations.
Some of the main competitors dominating the global surgical apparel market are Johnson & Johnson (US), Baxter International Inc. (US), Medtronic plc (US), Boston Scientific Corporation (US), GE Healthcare (US), Smith & Nephew plc (UK) and Covidien (Ireland).
